Ribociclib and Doxorubicin Hydrochloride in Treating Patients Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery
Conditions: Metastatic Angiosarcoma; Metastatic Epithelioid Sarcoma; Metastatic Fibrosarcoma; Metastatic Leiomyosarcoma; Metastatic Liposarcoma; Metastatic Malignant Peripheral Nerve Sheath Tumor; Metastatic Synovial Sarcoma; Metastatic Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma; Pleomorphic Rhabdomyosarcoma; Stage III Soft Tissue Sarcoma; Stage IV Soft Tissue Sarcoma; Undifferentiated (Embryonal) Sarcoma Interventions: Drug: Doxorubicin Hydrochloride; Drug: Ribociclib Sponsors: OHSU Knight Cancer Institute; National Cancer Institute (NCI) Not yet recruiting - verified December 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Angiosarcoma | Cancer & Oncology | Embryonal Carcinoma | Fibrosarcoma | Leiomyosarcoma | Liposarcoma | Rhabdomyosarcoma | Sarcomas | Soft Tissue Sarcoma